Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs
- 30 January 2007
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 109 (10) , 4245-4248
- https://doi.org/10.1182/blood-2006-08-039347
Abstract
Mesenchymal stromal cells (MSCs) have enormous potential for the regeneration of bone, cartilage, and other tissues derived from primitive mesoderm. Despite extensive research, there is still no single marker that reliably identifies MSCs within the bone marrow. Using immunocytochemistry and flow cytometry, we demonstrate here that the neural ganglioside GD2 is expressed by MSCs either newly isolated from bone marrow or expanded in tissue culture; this finding was supported by reverse transcriptase–polymerase chain reaction (RT-PCR) analysis showing expression of the mRNA for GD2 synthase, an essential enzyme for GD2 biosynthesis. GD2 was also expressed on MSCs isolated from adipose tissue, but not on foreskin fibroblasts. Importantly, MSCs were the only cells within normal marrow that expressed this marker. Thus, GD2 appears to be the first reported single surface marker that uniquely distinguishes MSCs from other marrow elements. GD2 may prove valuable to study MSC biology and for the preparation of MSCs for clinical applications.Keywords
This publication has 24 references indexed in Scilit:
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsThe Lancet, 2004
- Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritisArthritis & Rheumatism, 2004
- Adipogenic Differentiation of Human Adult Stem Cells From Bone Marrow Stroma (MSCs)Journal of Bone and Mineral Research, 2004
- Expression of Neuronal Markers in Differentiated Marrow Stromal Cells and CD133+ Stem-Like CellsCell Transplantation, 2003
- Isolation and characterization of bone marrow multipotential mesenchymal progenitor cellsArthritis & Rheumatism, 2002
- Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of boneProceedings of the National Academy of Sciences, 2002
- The SH-3 and SH-4 Antibodies Recognize Distinct Epitopes on CD73 from Human Mesenchymal Stem CellsBiochemical and Biophysical Research Communications, 2001
- Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.2001
- The Monoclonal Antibody SH-2, Raised against Human Mesenchymal Stem Cells, Recognizes an Epitope on Endoglin (CD105)Biochemical and Biophysical Research Communications, 1999